liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Early and intermediate stage Hodgkin's lymphoma - Report from the Swedish National Care Programme
Department of Oncology, Uppsala, Sweden, Dept. Oncol., Radiol.,/Clin. I., Rudbeck Laboratory, University Hospital, SE-751 85 Uppsala, Sweden.
Department of Oncology, Uppsala, Sweden.
Department of Oncology, Lund, Sweden.
Department of Oncology, Gothenburg, Sweden.
Show others and affiliations
2003 (English)In: European Journal of Haematology, ISSN 0902-4441, Vol. 70, no 3, 172-180 p.Article in journal (Refereed) Published
Abstract [en]

In Sweden a National Care Programme provides treatment principles for Hodgkin's lymphoma (HL) since 1985, for early and intermediate stages often less extensive than international recommendations. The purpose is to evaluate long-term results of these principles. A total of 308 patients (167 men and 141 women), 17-59 yr old (median 31), diagnosed during 1985-92, pathological stage (PS) I-III1A and I-IIB and clinical stage (CS) I-IIA, mean follow-up 8.8 yr, were studied. Staging laparotomy was recommended in CS IIA. Recommended treatment was mantle or mini-mantle radiotherapy (RT) alone in CS IA, and PS I-IIA and subtotal nodal irradiation in PS III1A if the disease was not bulky. Patients in PS I-IIA and III1A with bulky disease, and PS I-IIB received one cycle of mechlorethamine, vincristine, prednisone, procarbazine/doxorubicin, bleomycin, vinblastine, lacarbazine (MOPP/ABVD) before irradiation. The remaining patients received three to four cycles of MOPP/ABVD with RT to bulky disease. Relapse-free (RFS), Hodgkin specific (HLS), and overall survival (OS) at 10 yr were 74%, 92% and 85%. In the individual stages, RFS ranged from 53% (PSIII1A) to 90% (PS IA). RFS (P = 0.006), HLS, and OS were significantly better in patients treated with chemotherapy compared with those treated with RT alone, especially in patients with bulky disease (P = 0.0005). The international prognostic score did not provide any prognostic information. The OS rates are in agreement with results from international centres during that time. The recommended treatment was sufficient to produce the desired results of <20-30% recurrences, except in PS III1A. Most relapses could be salvaged. Patients with risk factors treated with one MOPP/ABVD and RT had an excellent outcome, superior to those without risk factors treated with RT alone. These results favour the trend to treat early and intermediate stages with a short course of chemotherapy followed by limited RT.

Place, publisher, year, edition, pages
2003. Vol. 70, no 3, 172-180 p.
Keyword [en]
Early stage, Hodgkin's lymphoma, Intermediate stage, Prognosis, Treatment
National Category
Natural Sciences
URN: urn:nbn:se:liu:diva-46705DOI: 10.1034/j.1600-0609.2003.00030.xOAI: diva2:267601
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2011-01-13

Open Access in DiVA

No full text

Other links

Publisher's full text
In the same journal
European Journal of Haematology
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 22 hits
ReferencesLink to record
Permanent link

Direct link